# Evaluating the Impact of Synbiotic Supplementation on Infants and Toddlers

> **NCT06746285** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Persephone Biosciences** · enrollment: 200 (estimated)

## Conditions studied

- Gastrointestinal Tolerance of Probiotics in Infants

## Interventions

- **DIETARY_SUPPLEMENT:** Synbiotic Supplement
- **DIETARY_SUPPLEMENT:** Lactose (inactive placebo)

## Key facts

- **NCT ID:** NCT06746285
- **Lead sponsor:** Persephone Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06746285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06746285, "Evaluating the Impact of Synbiotic Supplementation on Infants and Toddlers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06746285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*